A prospective randomised trial in order to determine the benefit of preoperative oral iron supplementation for patients undergoing elective colorectal cancer resection

ABSTRACT: Primary objectives: 1.To determine whether giving iron tablets to patients for 2 weeks before a colorectal cancer operation prevents or reduces anaemia requiring blood transfusion. Primary endpoint: Blood transfusion requirement Secondary endpoints: Change in haemoglobin produced by oral iron supplementsSide effect profile produced by oral iron supplements

DISEASE(S): Colorectal Cancer

PROVIDER: 2517978 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR